These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 179130)

  • 1. mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. I. Clinical aspects.
    Jonsson V; Videbek A; Axelsen NH; Harboe M
    Scand J Haematol; 1976 Mar; 16(3):209-17. PubMed ID: 179130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. II. Immunochemical studies.
    Axelsen NH; Harboe M; Jonsson V; Videbaek AA
    Scand J Haematol; 1976 Mar; 16(3):218-25. PubMed ID: 179131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-chain disease.
    Franklin EC
    Arch Intern Med; 1975 Jan; 135(1):71-2. PubMed ID: 1111471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu-heavy chain disease associated with systemic amyloidosis.
    Kinoshita K; Yamagata T; Nozaki Y; Sugiyama M; Ikoma S; Funauchi M; Kanamaru A
    Hematology; 2004 Apr; 9(2):135-7. PubMed ID: 15203869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete variable region deletion in a mu heavy chain disease protein (ROUL). Correlation with light chain secretion.
    Cogné M; Aucouturier P; Brizard A; Dreyfus B; Duarte F; Preud'homme JL
    Leuk Res; 1993 Jun; 17(6):527-32. PubMed ID: 8505850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease].
    Tamura A; Yamashiro A; Mizutani F; Oita T; Maeda A; Takahashi T
    Rinsho Byori; 2003 Sep; 51(9):847-51. PubMed ID: 14560651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cast nephropathy in mu heavy chain disease.
    Preud'homme JL; Bauwens M; Dumont G; Goujon JM; Dreyfus B; Touchard G
    Clin Nephrol; 1997 Aug; 48(2):118-21. PubMed ID: 9285150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mu-chain disease. Report of two new cases.
    Brouet JC; Seligmann M; Danon F; Belpomme D; Fine JM
    Arch Intern Med; 1979 Jun; 139(6):672-4. PubMed ID: 109059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-induced switching of immunoglobulin heavy-chain class secretion in chronic B-lymphocytic leukaemia and immunocytoma cell populations.
    Juliusson G; Robèrt KH; Hammarström L; Smith CI; Biberfeld G; Gahrton G
    Scand J Immunol; 1983 Jan; 17(1):51-9. PubMed ID: 6405478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new case of heavy mu-chain disease.
    Danon F; Mihaesco C; Bouvry M; Clerc M; Seligmann M
    Scand J Haematol; 1975 Aug; 15(1):5-9. PubMed ID: 170667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic leukaemia and IgG heavy chain disease.
    Briët E; van Nieuwkoop JA; Jol-vd Zijde CM; den Ottolander GJ; Rádl J
    Scand J Haematol; 1980 Sep; 25(3):244-50. PubMed ID: 7008181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies.
    Foroni L; Catovsky D; Rabbitts TH; Luzzatto L
    Mol Biol Med; 1984 Feb; 2(1):63-79. PubMed ID: 6439975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma (light chain disease) with rheumatoid-like amyloid arthropathy and mu-heavy chain fragment in the serum.
    Pruzanski W; Hasselback R; Katz A; Parr DM
    Am J Med; 1978 Aug; 65(2):334-41. PubMed ID: 99035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodular glomerulosclerosis secondary to mu heavy chain deposits.
    Liapis H; Papadakis I; Nakopoulou L
    Hum Pathol; 2000 Jan; 31(1):122-5. PubMed ID: 10665924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune phenotype and prognosis in chronic B-lymphocytic leukaemia and leukaemic immunocytoma.
    Juliusson G; Ost A; Biberfeld P; Robèrt KH; Gahrton G
    Acta Med Scand; 1985; 218(3):335-40. PubMed ID: 3878068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia.
    Ha K; Minden M; Hozumi N; Gelfand EW
    J Clin Invest; 1984 Apr; 73(4):1232-6. PubMed ID: 6423668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-chain disease.
    Lee SL; Rosner F; Ruberman W; Glasberg S
    Ann Intern Med; 1971 Sep; 75(3):407-14. PubMed ID: 5568152
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heavy chain diseases].
    Seligmann M
    Rev Prat; 1993 Feb; 43(3):317-20. PubMed ID: 8502962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some impacts of clinical investigation on immunology. Surface IgD, IgE, and heavy-chain variants.
    Franklin EC
    N Engl J Med; 1976 Mar; 294(10):531-7. PubMed ID: 814459
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of proliferation and differentiation of leukaemic B cells from patients with chronic lymphocytic leukaemia by anti-mu and conditioned medium.
    Steinberg J; Moore MA; Bernhardt B; Bona CA; Platsoucas CD
    Scand J Immunol; 1987 Jun; 25(6):599-611. PubMed ID: 3110941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.